These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2372903)
61. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. Unterberg C; Sandrock D; Nebendahl K; Buchwald AB J Am Coll Cardiol; 1995 Dec; 26(7):1747-54. PubMed ID: 7594113 [TBL] [Abstract][Full Text] [Related]
62. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464 [TBL] [Abstract][Full Text] [Related]
63. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model. Gosselin C; Ren D; Ellinger J; Greisler HP Am J Surg; 1995 Aug; 170(2):126-30. PubMed ID: 7543261 [TBL] [Abstract][Full Text] [Related]
64. The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model. Trocciola SM; Dayal R; Chaer RA; Lin SC; DeRubertis B; Ryer EJ; Hynececk RL; Pierce MJ; Prince M; Badimon J; Marin ML; Fuster V; Kent KC; Faries PL J Vasc Surg; 2006 Jan; 43(1):109-16. PubMed ID: 16414397 [TBL] [Abstract][Full Text] [Related]
66. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist. Kotzé HF; Lamprecht S; Badenhorst PN; van Wyk V; Roodt JP; Alexander K Thromb Haemost; 1993 Oct; 70(4):672-5. PubMed ID: 8115994 [TBL] [Abstract][Full Text] [Related]
67. Induction of transient neurological dysfunction in baboons by platelet microemboli. Kessler C; Kelly AB; Suggs WD; Weissman JD; Epstein CM; Hanson SR; Harker LA Stroke; 1992 May; 23(5):697-702. PubMed ID: 1533737 [TBL] [Abstract][Full Text] [Related]
69. Evaluation of expanded polytetrafluoroethylene-covered stents for the treatment of venous outflow stenosis in hemodialysis access grafts. Chan MG; Miller FJ; Valji K; Kuo MD J Vasc Interv Radiol; 2011 May; 22(5):647-53. PubMed ID: 21371910 [TBL] [Abstract][Full Text] [Related]
70. Comparison of direct site endovascular repair utilizing expandable polytetrafluoroethylene stent grafts versus standard vascular shunts in a porcine (Sus scrofa) model. Davidson AJ; Neff LP; Grayson JK; Clement NF; DeSoucy ES; Simon Logan MA; Abbot CM; Sampson JB; Williams TK J Trauma Acute Care Surg; 2017 Sep; 83(3):457-463. PubMed ID: 28846579 [TBL] [Abstract][Full Text] [Related]
71. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678 [TBL] [Abstract][Full Text] [Related]
72. Effects of balloon dilatation on ePTFE structural characteristics. Salzmann DL; Yee DC; Roach DJ; Berman SS; Williams SK J Biomed Mater Res; 1997 Sep; 36(4):498-507. PubMed ID: 9294765 [TBL] [Abstract][Full Text] [Related]
73. Extracellular matrix preparation of expanded polytetrafluoroethylene grafts seeded with endothelial cells: influence on early platelet deposition, cellular growth, and luminal prostacyclin release. Köveker GB; Graham LM; Burkel WE; Sell R; Wakefield TW; Dietrich K; Stanley JC Surgery; 1991 Mar; 109(3 Pt 1):313-9. PubMed ID: 2000563 [TBL] [Abstract][Full Text] [Related]
74. The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep. Lundell A; Bergqvist D; Lindblad B Eur J Vasc Surg; 1993 Nov; 7(6):698-703. PubMed ID: 8270074 [TBL] [Abstract][Full Text] [Related]
75. Mechanism of antithrombotic effect of heparin and antithrombin in balloon-injured arteries. Tomaru T; Kawano HA; Tsujiuchi Y; Suzuki J; Nakajima T; Uchida Y Life Sci; 2005 Oct; 77(21):2611-25. PubMed ID: 16005470 [TBL] [Abstract][Full Text] [Related]
76. Evaluation of the thrombogenecity of microvascular prosthesis by in vivo microscopy. Kim YB; Reisch HP; Serafin D; Klitzman B J Korean Med Sci; 1994 Oct; 9(5):357-61. PubMed ID: 7702782 [TBL] [Abstract][Full Text] [Related]
77. Acute thrombogenicity of intact and injured natural blood conduits versus synthetic conduits: neutrophil, platelet, and fibrin(ogen) adsorption under various shear-rate conditions. Merhi Y; King M; Guidoin R J Biomed Mater Res; 1997 Mar; 34(4):477-85. PubMed ID: 9054531 [TBL] [Abstract][Full Text] [Related]
79. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB; Morrissey NJ; J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929 [TBL] [Abstract][Full Text] [Related]
80. Radionuclide study of platelets and prosthetic interactions: external versus specimen quantitation. Nordestgaard AG; Marcus CS; Wilson SE J Invest Surg; 1988; 1(1):28-34. PubMed ID: 3154077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]